For example, over the past several years, we have completed major improvements to our facilities and laboratory equipment. We have also grown our staff by over 100 percent to accommodate stringent testing criteria. And we have rigorously trained all our employees on our extensive instrument inventory. We also routinely collaborate with manufacturers to stay ahead of the information and technology curve. We have developed an extensive library of internal Standard Operating Procedures (SOPs) and continue to expand our test capabilities and methodologies in analytical chemistry and microbiology.
Most recently, we have delved into the uncharted territory of CBD, cannabis, and hemp testing; taking on the challenge of using complex instrumentation to validate and analyze samples for heavy metals, potency, microbiology, and toxins in a CGMP facility. NJ Labs will continue to pursue the potential of this growing industry.
For over eighty years, we have continued to grow with our clients to meet their research and development needs while addressing the aggressive increase in demands from regulatory bodies. We are prepared and excited to be a part of our clients’ growth and progression as we continue into the 21st century.
Chief Executive Officer